Skip to main content

Table 2 Feasibility and tolerability

From: Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer

  1. NAC Neoadjuvant chemotherapy, SD Standard deviation, IQR Interquartile range, RDI Relative dose intensity
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us